Intestinal Cell News Volume 9.44 | Nov 24 2023

    0
    8








    2023-11-24 | ICN 9.44


    Intestinal Cell News by STEMCELL Technologies
    Vol. 9.44 – 24 November, 2023
    TOP STORY

    Partial In Vivo Reprogramming Enables Injury-Free Intestinal Regeneration via Autonomous Ptgs1 Induction

    Researchers induced dedifferentiation of intestinal epithelial cells using Oct4, Sox2, Klf4, and c-Myc (OSKM) in vivo. The OSKM-induced forced dedifferentiation showed similar molecular features of intestinal regeneration.
    [Science Advances]

    Full Article
    Culture Mouse Intestinal Organoids With On-Demand Training. Learn More
    PUBLICATIONSRanked by the impact factor of the journal

    Enhancement of Efferocytosis through Biased FPR2 Signaling Attenuates Intestinal Inflammation

    Scientists reported the identification of columbamine which enhanced macrophage-mediated efferocytosis and attenuated intestinal inflammation in a murine colitis model.
    [EMBO Molecular Medicine]

    Full ArticleGraphical Abstract

    Remodeling of Intestinal Epithelium Derived Extracellular Vesicles by Nanoparticles and Its Bioeffect on Tumor Cell Migration

    Researchers studied the interaction between nanoparticles and intestinal epithelial cells, as well as their bioeffects on downstream cells from the perspective of extracellular vesicles.
    [Journal of Controlled Release]

    AbstractGraphical Abstract

    Mutant p53 Gain-of-Function Stimulates Canonical Wnt Signaling via PI3K/AKT Pathway in Colon Cancer

    Using the TCGA public data from Pan-Cancer and the GEPIA2 platform, an in silico analysis of wt-p53 versus mut-p53 genotyped colorectal cancer patients showed that TP53 and CTNNB1 were significantly overexpressed in colorectal cancer, compared with normal tissue.
    [Journal of Cell Communication and Signaling]

    Full ArticleGraphical Abstract

    Protease-Activated Receptor 2 Attenuates Doxorubicin-Induced Apoptosis in Colon Cancer Cells

    Scientists investigated a possible mechanistic link between PAR2 activation of intracellular signaling and pro-survival events in HT29 human colon cancer cells, then identified possible strategies to restore doxorubicin effects.
    [Journal of Cell Communication and Signaling]

    AbstractGraphical Abstract

    Arabinose Confers Protection against Intestinal Injury by Improving Integrity of Intestinal Mucosal Barrier

    Arabinose was recognized as a significant and inherent protector of the intestinal mucosal barrier through its role in preserving the integrity of tight junctions within the intestines.
    [International Immunopharmacology]

    Abstract

    Reduced LHFPL3-AS2 lncRNA Expression Is Linked to Altered Epithelial Polarity and Proliferation, and to Ileal Ulceration in Crohn Disease

    Investigators identified a widespread reduction in the expression of lncRNAs including LHFPL3-AS2 in the treatment-naïve Crohn disease ileum of the RISK pediatric cohort.
    [Scientific Reports]

    Full Article

    Low Expression of ZHX3 Is Associated with Progression and Poor Prognosis in Colorectal Cancer

    Scientists analyzed the protein levels of ZHX3 by immunohistochemistry and evaluated its relationship with the clinicopathological features and prognosis in 286 colorectal cancer patients.
    [Translational Oncology]

    Full Article

    SOX8 Promotes Tumor Growth and Metastasis through FZD6-Dependent Wnt/β-Catenin Signaling in Colorectal Carcinoma

    Data showed that SOX8 expression was upregulated in colorectal carcinoma (CRC) cell lines and tumor tissues. Stable knockdown of SOX8 in CRC cell lines dramatically reduced cell proliferation, migration, and invasion.
    [Heliyon]

    Full Article
    See how small molecules affect key signaling pathways in cancer research. Download your free wallchart now.
    REVIEWS

    Engineered Synthetic Matrices for Human Intestinal Organoid Culture And Therapeutic Delivery

    Human intestinal organoids derived from pluripotent stem cells or adult stem cell biopsies represent a powerful platform to study human development, drug testing, and disease modeling in vitro, and serve as a cell source for tissue regeneration and therapeutic advances in vivo.
    [Advanced Materials]

    Abstract
    INDUSTRY AND POLICY NEWS

    University of Bonn Receives Three ERC Consolidator Grants

    Another big success for the University of Bonn in securing grants from the European Research Council (ERC), with three researchers receiving an ERC Consolidator Grant: Drs. Jan Hasenauer, Florian I. Schmidt, and Evgeny Shinder.
    [University of Bonn]

    Press Release
    FEATURED EVENT

    9th International Conference on Mechanics of Biomaterials and Tissues

    December 16 – 20, 2023
    Waikoloa Beach, Hawaii, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Researchers – Skin and Mucosa Inflammation, Immunity & Tissue Regeneration

    Temple University – Philadelphia, Pennsylvania, United States

    Postdoctoral Fellowships – Cancer Research

    NIH National Cancer Institute – Bethesda, Maryland, United States

    Postdoctoral Researcher – Cancer Bioinformatics and Immunotherapies

    Armenian Bioinformatics Institute – Yerevan, Armenia

    Research Assistant – Epigenetics

    Babraham Institute – Cambridge, England, United Kingdom

    Postdoctoral Fellow – Immunology and Colon Cancer

    University of Texas MD Anderson Cancer Center – Houston, Texas, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2